| ICHAI, Carole R |
NCT04141371: Molar Sodium Lactate Filling in Severe Meningeal Hemorrhage |
|
|
| Recruiting | 3 | 38 | Europe | Molar Sodium Lactate, physiological serum | Centre Hospitalier Universitaire de Nice | Subarachnoid Hemorrhage, Aneurysmal | 05/22 | 01/25 | | |
| Completed | 3 | 700 | Europe | Inhaled sedation with sevoflurane, intravenous sedation with propofol | University Hospital, Clermont-Ferrand | Acute Respiratory Distress Syndrome | 10/23 | 10/24 | | |
ECRO, NCT03426943: Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™ |
|
|
| Completed | N/A | 39 | Europe | Arterial blood sampling, Ultrafiltrate sampling, CVVH using oXiris™ filter, CVVH using PrismafleX HF1400 filter | Hospices Civils de Lyon, Baxter Healthcare Corporation | Septic Shock, Peritonitis | 06/22 | 06/22 | | |
| Recruiting | N/A | 660 | Europe | Extubation readiness clinical score, Standard of care | University Hospital, Clermont-Ferrand, AZUREA Network (www.azurea.org), ANARLF Network, Direction Générale de l'Offre de Soin (DGOS) | Mechanical Ventilator Weaning, Acute Brain Injury, Altered Level of Consciousness, Mechanical Ventilation, Airway Control | 02/27 | 10/27 | | |
| PAUL, Carle |
METVI, NCT04237103: Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults with Progressive Vitiligo |
|
|
| Recruiting | 2 | 45 | Europe | Methotrexate, narrow-band UVB phototherapy, Placebos | University Hospital, Bordeaux | Vitiligo | 10/25 | 10/25 | | |
PREPCOV, NCT04481633: Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection |
|
|
| Recruiting | N/A | 800 | Europe | COVID 19 serology, COVID 19 Self-Questionnaire | University Hospital, Toulouse | COVID-19 | 03/22 | 03/22 | | |
ADlupus, NCT06506214: Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus |
|
|
| Recruiting | N/A | 233 | Europe | Questionnaires | University Hospital, Toulouse | Cutaneous Lupus | 10/24 | 10/24 | | |
| LEBRUN-FRENAY, Christine |
TERIS, NCT03122652: Randomized, Double-blinded Study of Treatment:Teriflunomide, in Radiologically Isolated Syndrome |
|
|
| Completed | 3 | 125 | Europe, RoW | Teriflunomide 14 MG Oral Tablet [Aubagio], Placebo Oral Tablet | Centre Hospitalier Universitaire de Nice, Genzyme, a Sanofi Company | Multiple Sclerosis | 02/19 | 10/22 | | |
| Recruiting | 3 | 486 | Europe | Intensified protocol, Stupp protocol | Centre Oscar Lambret, Association de Neuro-Oncologues d'Expression Francaise, Erasme University Hospital | Glioblastoma | 05/25 | 11/27 | | |
STOP-I-SEP, NCT03653273: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years |
|
|
| Recruiting | 3 | 250 | Europe | DMT withdrawal, DMT continuation | Rennes University Hospital | Multiple Sclerosis | 07/26 | 01/28 | | |
TRIO, NCT05758831: RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis. |
|
|
| Recruiting | 3 | 386 | Europe | Perfusion of treatment Rituximab, Perfusion of treatment Ocrelizumab | Rennes University Hospital | Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis | 03/30 | 05/30 | | |
| Completed | N/A | 32 | Europe | Vivomixx | Centre Hospitalier Universitaire de Nice | HIV, Neurocognitive Disorders | 12/21 | 05/24 | | |
| Recruiting | N/A | 160 | Europe | NO INTERVENTION | Centre Hospitalier Universitaire de Nice | Multiple Sclerosis, Radiologically Isolated Syndrome, Epstein-Barr Virus | 06/24 | 06/24 | | |
| Completed | N/A | 68 | Europe, RoW | Questionnaire | University Hospital, Bordeaux, Biogen | Multiple Sclerosis | 12/23 | 12/23 | | |
NeurofilMS, NCT03981003: Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis |
|
|
| Recruiting | N/A | 1150 | Europe, RoW | Blood sample | Centre Hospitalier Universitaire de Nīmes, Hospices Civils de Lyon | Multiple Sclerosis | 06/28 | 06/28 | | |
| Recruiting | N/A | 1000 | Europe, RoW | No intervention | Hospices Civils de Lyon | Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal | 08/36 | 08/36 | | |
| Recruiting | N/A | 1000 | Europe | No intervention | Centre Hospitalier Universitaire de Nice | Multiple Sclerosis, Radiologically Isolated Syndrome | 04/23 | 04/29 | | |
| ROBERT, Philippe |
| Recruiting | N/A | | Europe | non ontervention / observational study | Centre Hospitalier Universitaire de Nice | Alzheimer Disease | 01/09 | 12/25 | | |
NCT04573985: Impact of the Eurékoi Serious Game on Family Caregivers of Patients With a Major Neurocognitive Disorder |
|
|
| Completed | N/A | 40 | Europe | Serious game Eurekoi intervention | Centre Hospitalier Universitaire de Nice | Family Caregiver of Patient With Alzheimer Disease | 09/22 | 09/22 | | |
| Completed | N/A | 57 | Europe | Follow up and Assessment | Centre Hospitalier Universitaire de Nice | Apathy, Fatigue | 12/21 | 12/21 | | |
| ANTY, Rodolphe |
EASY, NCT06354179: Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation |
|
|
| Not yet recruiting | 4 | 162 | Europe | XR-tacrolimus QD + MMF BID then MMF QD, XR-tacrolimus QD + MMF BID, LCP-tacrolimus QD + MMF QD then MMF QD, LCP-tacrolimus QD + MMF BID | University Hospital, Limoges | Liver Transplantation, Immunosuppression | 02/28 | 02/28 | | |
ProPILARifax, NCT03069131: Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites |
|
|
| Completed | 3 | 160 | Europe | Rifaximin, Placebo | Centre Hospitalier Universitaire de Besancon, Alfasigma S.p.A., LC2 PHARMA | Cirrhosis, Ascites, Peritonitis | 06/22 | 03/23 | | |
AB-LATE02, NCT04727307: Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial |
|
|
| Recruiting | 2 | 202 | Europe | Atezolizumab (neoadjuvant), Tecentriq, Percutaneous Radiofrequency, Bevacizumab (adjuvant), Avastin 400 mg in 16 ml Injection, Avastin 100 mg in 4 ml Injection, Atezolizumab (adjuvant) | University Hospital, Montpellier | Hepatocellular Carcinoma | 02/26 | 02/31 | | |
NCT03695796: French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort) |
|
|
| Recruiting | N/A | 1000 | Europe | biopsy-proven NAFLD patients with non-invasive tests of liver fibrosis (blood tests, elastography devices) and biobank | University Hospital, Angers | NAFLD | 11/24 | 12/24 | | |
STEATO-APA, NCT04835831: Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease |
|
|
| Recruiting | N/A | 105 | Europe | adapted physical activity + Dietetic advice | Centre Hospitalier Universitaire de Nice | Non-Alcoholic Fatty Liver Disease (NAFLD | 06/22 | 04/26 | | |
| Active, not recruiting | N/A | 23 | Europe | nasopharyngeal Covid 19 RT-PCR | Centre Hospitalier Universitaire, Amiens, Centre Hospitalier-Universitaire Bondy, University Hospital, Bordeaux, Centre Hospitalier-Universitaire CLICHY, Centre Hospitalier Général CORBEIL-ESSONNE, CHU CRETEIL, University Hospital, Grenoble, University Hospital, Lille, CHU LYON, Poitiers University Hospital, Rennes University Hospital, University Hospital, Rouen, University Hospital, Toulouse, CHU VILLEJUIF, Central Hospital, Nancy, France, Centre Hospitalier Universitaire de Nice, University Hospital, Montpellier | Hepatocellular Carcinoma, COVID-19 | 10/23 | 10/24 | | |
| Recruiting | N/A | 720 | Europe | Post-transplant addiction intervention | University Hospital, Montpellier | Alcohol Associated Liver Disease, Liver Transplantation | 09/26 | 09/28 | | |
| Not yet recruiting | N/A | 150 | Europe | Corticosteroid therapy | Assistance Publique - Hôpitaux de Paris | Liver Failure, Acute, Hepatitis, Autoimmune, Organ Dysfunction Scores, Risk Factors | 05/27 | 06/28 | | |
| Dellamonica, Jean |
| Completed | N/A | 303 | Europe | blood sampling, additional blood tubes | Centre Hospitalier Universitaire de Nice | New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2 | 12/21 | 06/22 | | |
NCT04690530: Cerebral Hemodynamics and Oxygenation in Critically Ill Patients |
|
|
| Not yet recruiting | N/A | 60 | Europe | mechanical ventilation, Sedation | Centre Hospitalier Universitaire de Nice | Septic Shock | 03/22 | 03/22 | | |
| Completed | N/A | 9 | Europe | bronchoalveolar lavage | Centre Hospitalier Universitaire de Nice | Drowning | 07/23 | 07/23 | | |
| Recruiting | N/A | 250 | Europe | Spontaneous breathing trial | Centre Hospitalier Universitaire de Nice | Mechanical Ventilation Complication, Pulmonary Edema | 08/24 | 09/24 | | |
| Recruiting | N/A | 740 | Europe, Canada, US, RoW | Respiratory Mechanics, Standard Ventilation Strategy | Unity Health Toronto, Canadian Institutes of Health Research (CIHR), University of Toronto, Applied Health Research Centre | ARDS | 11/25 | 03/26 | | |
| Recruiting | N/A | 500 | Europe | | Centre Hospitalier Universitaire de Nice, Institut National de Recherche en Informatique et en Automatique, AIINTENSE | Cardio Respiratory Arrest | 12/20 | 12/20 | | |
| Bahadoran, Philippe |
| Recruiting | 2 | 50 | Europe | Tirbanibulin, Tirbaso | Centre Hospitalier Universitaire de Nice | Cell Carcinoma | 12/24 | 12/25 | | |
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary |
|
|
| Recruiting | N/A | 6000 | Europe | Biological, Tissular, Quality of life | Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI) | Malignant Melanoma | 03/24 | 03/24 | | |
| RICHARD, Marie-Aleth |
RITUX-MMP, NCT03295383: Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid |
|
|
| Recruiting | 3 | 130 | Europe | Rituximab 1g IV, Cyclophosphamide 50Mg Oral Tablet, Placebo of Rituximab, Placebo Oral Tablet | University Hospital, Rouen | Severe Forms of Mucous Membrane Pemphigoid | 11/22 | 11/23 | | |
| Not yet recruiting | 3 | 92 | Europe | ROCEPHIN, metronidazole, RIFADIN, IZILOX, placebo combination therapy, Experimental treatment, Lymecyclin and corresponding placebos of the experimental arm, Control treatment | Institut Pasteur, Centre Hospitalier Universitaire de Caen, Hôpital Necker-Enfants Malades, Ministry of Health, France, Assistance Publique Hopitaux De Marseille | Hidradenitis Suppurativa | 12/25 | 09/26 | | |
| Recruiting | 2/3 | 474 | Europe, Canada, Japan, US, RoW | Litifilimab, BIIB059, Placebo | Biogen, Biogen Idec Research Limited | Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus | 10/26 | 12/27 | | |
| Recruiting | 2 | 74 | Europe | Itacitinib, Placebo | Assistance Publique - Hôpitaux de Paris | Systemic Sclerosis | 02/26 | 02/26 | | |
| Recruiting | N/A | 900 | Europe | | Institut National de la Santé Et de la Recherche Médicale, France | Inherited Epidermolysis Bullosa, Ichthyosis, Ectodermal Dysplasia, Incontinentia Pigmenti, Neurofibromatosis Type 1, Albinism, Pemphigus, Mucous Membrane Pemphigoid, Palmoplantar Keratoderma | 03/27 | 03/27 | | |
| SACCO, Guillaume |
| Recruiting | 2 | 282 | Europe, Canada, US, RoW | GSK4527226, Placebo | GlaxoSmithKline, Alector Inc. | Alzheimer's Disease | 12/26 | 02/29 | | |
| Recruiting | N/A | 170 | Europe | MBI-C Scale in French | University Hospital, Toulouse | Subjective Cognitive Complaint, Mild Cognitive Impairment, Neuropsychiatric Symptoms | 07/25 | 07/25 | | |
| Recruiting | N/A | 30 | Europe | speech therapy | Centre Hospitalier Universitaire de Nice | Stroke | 11/24 | 03/25 | | |
| Completed | N/A | 200 | Europe | Ultrasound measurement | Centre Hospitalier Universitaire de Nice | Sarcopenia | 08/23 | 08/23 | | |
| Recruiting | N/A | 34 | Europe | APA, PAE | Centre Hospitalier Universitaire de Nice | Neurocognitive Disorders | 11/24 | 11/25 | | |
DiME, NCT06242574: Meaningful Aspects of Health for Adults With Dementia, Their Care Partners and Healthcare Practitioners |
|
|
| Withdrawn | N/A | 175 | Europe | Survey | Centre Hospitalier Universitaire de Nice | Alzheimer Disease | 03/25 | 03/25 | | |
| Recruiting | N/A | 32 | Europe | Functional Proprioceptive Stimulation | Centre Hospitalier Universitaire de Nice | Stroke (CVA) or TIA | 01/25 | 04/25 | | |
ARN-MA, NCT06523296: Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients. |
|
|
| Recruiting | N/A | 30 | Europe | Adults with Alzheimer's disease, Adults with Myasthenia, Healhty controls | Centre Hospitalier Universitaire de Nice | Alzheimer Disease, Myasthenia | 10/26 | 11/26 | | |
VR4IC, NCT06597591: Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders |
|
|
| Recruiting | N/A | 48 | Europe | VR headset, Tablet | Centre Hospitalier Universitaire de Nice | Cognitive Disorder | 05/27 | 11/27 | | |
| CARLES, Michel |
| Completed | N/A | 175 | Europe | Blood sample taken | Centre Hospitalier Universitaire de Nice | Sepsis | 06/23 | 06/23 | | |
| Leroy, Sylvie |
EXAFIP2, NCT05674994: Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 3 | 110 | Europe | Methylprednisone/Prednisone, Placebo | Fondation Hôpital Saint-Joseph | Acute Exacerbation of Idiopathic Pulmonary Fibrosis | 10/25 | 12/26 | | |
CHOICES, NCT06468527: Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF |
|
|
| Recruiting | 2 | 52 | Europe | Diponecaftor, Placebo | Kors van der Ent, European Union | Cystic Fibrosis | 04/25 | 06/25 | | |
ANTEIPA, NCT06368804: Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis |
|
|
| Recruiting | 2 | 196 | Europe | Antibiotic monotherapy treatment and follow-up, Antibiotic bitherapy treatment and follow-up | Centre Hospitalier Intercommunal Creteil, Assistance Publique - Hôpitaux de Paris | Bronchiectasis | 03/25 | 09/28 | | |
KAF-BIOTA, NCT05937815: Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor |
|
|
| Recruiting | N/A | 253 | Europe | Sample collection | University Hospital, Bordeaux | Cystic Fibrosis | 09/23 | 09/24 | | |
MUCOSIM, NCT04010253: Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis |
|
|
| Recruiting | N/A | 42 | Europe | SIMEOX, Autogenic drainage | Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | Cystic Fibrosis | 12/23 | 12/23 | | |
DISCOVAIR, NCT04529993: An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls |
|
|
| Recruiting | N/A | 46 | Europe | Bronchoscopy | Centre Hospitalier Universitaire de Nice | Pulmonary Disease, Chronic Obstructive, Interstitial Pulmonary Fibrosis | 01/25 | 01/25 | | |
| Recruiting | N/A | 160 | Europe | SIMEOX | Physio-Assist, Icadom | Pulmonary Cystic Fibrosis | 12/24 | 06/25 | | |
MuControl, NCT06147778: Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis |
|
|
| Recruiting | N/A | 70 | Europe | MuCopilot mobile application | Ad scientiam, Vertex Pharmaceuticals Incorporated | Cystic Fibrosis | 09/25 | 09/25 | | |
| Not yet recruiting | N/A | 622 | Europe, RoW | SIMEOX, Remote Physiotherapy | Physio-Assist, Icadom, Clinact | Non-cystic Fibrosis Bronchiectasis | 12/27 | 12/27 | | |
NCT05810493: A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up |
|
|
| Recruiting | N/A | 1500 | Europe | Observation | Centre Hospitalier Universitaire de Nice | Interstitial Lung Disease | 12/25 | 12/25 | | |
| POIREE, MARILYNE |
CURALASE01, NCT04596410: Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children |
|
|
| Recruiting | N/A | 406 | Europe | LLLT applied every other day, LLLT applied daily | University Hospital, Toulouse | Mucositis Oral | 01/24 | 02/24 | | |
| SEITZ-POLSKI, Barbara |
NCT03804359: Personalized Medicine for Membranous Nephropathy |
|
|
| Recruiting | 2 | 64 | Europe | Rituximab | Centre Hospitalier Universitaire de Nice | Idiopathic Membranous Nephropathy | 09/23 | 09/23 | | |
QuantiFERON, NCT03572842: Functional Non Specific Immunity Monitoring After Kidney Transplantation Using an Interferon Gamma Test |
|
|
| Completed | N/A | 134 | Europe | quantiferon monitor test | Centre Hospitalier Universitaire de Nice | Kidney Transplantation | 01/21 | 10/23 | | |
| Completed | N/A | 303 | Europe | blood sampling, additional blood tubes | Centre Hospitalier Universitaire de Nice | New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2 | 12/21 | 06/22 | | |
| Completed | N/A | 175 | Europe | Blood sample taken | Centre Hospitalier Universitaire de Nice | Sepsis | 06/23 | 06/23 | | |
| Sacconi, Sabrina |
| Terminated | 3 | 260 | Europe, Canada, US | Losmapimod, Placebo oral tablet | Fulcrum Therapeutics | Facioscapulohumeral Muscular Dystrophy (FSHD) | 11/24 | 11/24 | | |
THERAMAG, NCT05136976: Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders |
|
|
| Recruiting | 3 | 90 | Europe | Rituximab infusion, Mabthera, Placebo infusion, Sodium chloride (NaCl), Premedications | Centre Hospitalier Universitaire de Saint Etienne, Ministry of Health, France | Anti-MAG Neuropathy | 12/25 | 12/25 | | |
| Recruiting | 2 | 40 | Europe, Canada | Satralizumab Prefilled Syringe, Placebo Comparator | Centre Hospitalier Universitaire de Nice | Facioscapulohumeral Muscular Dystrophy 1 | 01/27 | 01/27 | | |
| Active, not recruiting | 2 | 180 | Europe, US | KL1333, Placebo | Abliva AB | Primary Mitochondrial Disease | 10/25 | 12/25 | | |
ARDA+, NCT05405361 / 2021-004998-32: A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults with Multifocal Motor Neuropathy |
|
|
| Active, not recruiting | 2 | 51 | Europe, Canada, US | ARGX-117, Placebo | argenx, argenx BV | Multifocal Motor Neuropathy (MMN) | 09/26 | 09/26 | | |
SMOB, NCT04690998: Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients |
|
|
| Active, not recruiting | N/A | 104 | Europe | Blood Samples, MRI | Assistance Publique Hopitaux De Marseille | Spinal Muscular Atrophy | 10/23 | 10/25 | | |
TELEKINECT, NCT05597592: Experimentation of a Personalized Physical Self-education Program at Home: Feasibility Study (PROSOL ) |
|
|
| Withdrawn | N/A | 17 | Europe | Feasability of a personalised physical rehabilitation program at home | Centre Hospitalier Universitaire de Nice | Neuromuscular Diseases, Neurodegenerative Diseases | 10/23 | 10/23 | | |
GoodDiagNMD, NCT06270186: Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality Approach |
|
|
| Withdrawn | N/A | | NA | Type 1 myotonic dystrophy | Centre Hospitalier Universitaire de Nice | Myotonic Dystrophy 1 | 11/24 | 11/24 | | |
MNDActivLife, NCT06136416: Pilot Study for the Development of an Activity and Quality of Life Questionnaire for the Follow-up of Patients With Non-dystrophic Myotonia |
|
|
| Completed | N/A | 10 | Europe | Questionnaire for Non-dystrophic myotonias | Centre Hospitalier Universitaire de Nice | Non-Dystrophic Myotonia | 05/24 | 05/24 | | |
| Active, not recruiting | N/A | 70 | Europe | Remote monitoring program | Centre Hospitalier Universitaire de Nice | Type 1 Facioscapulohumeral Muscular Dystrophy | 03/25 | 03/25 | | |
NCT06815133: Effectiveness and Safety of Zilucoplan Treatment for French Patients with Myasthenia Gravis Over 3 Months |
|
|
| Not yet recruiting | N/A | 55 | Europe | Zilbrysq | Centre Hospitalier Universitaire de Nice | Myasthenia Gravis | 11/25 | 03/26 | | |
| Withdrawn | N/A | 20 | Europe | Psyllium | Centre Hospitalier Universitaire de Nice | Familial Amyloidosis | 05/25 | 05/25 | | |
SMAII, NCT04159987: Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA® |
|
|
| Completed | N/A | 20 | Europe | Spinraza intrathecal injection | Centre Hospitalier Universitaire de Nice | Spinal Muscular Atrophy | 07/24 | 07/24 | | |
| Active, not recruiting | N/A | 100 | Europe | Validation of new COA for FSHD patients | Centre Hospitalier Universitaire de Nice | Muscular Dystrophy, Facioscapulohumeral | 09/25 | 09/25 | | |
| Active, not recruiting | N/A | 413 | Europe, Canada, Japan, US, RoW | | argenx | Multifocal Motor Neuropathy | 11/25 | 11/25 | | |
ADVANCED, NCT05453461: FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study |
|
|
| Recruiting | N/A | 30 | Europe | Validation of new COMs for non ambulant FSHD patients | Centre Hospitalier Universitaire de Nice | Facioscapulohumeral Muscular Dystrophy | 04/27 | 04/27 | | |
INSIGHT FSHD2, NCT06079567: An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression |
|
|
| Recruiting | N/A | 50 | Europe | Validation of new COMs for FSHD2 patients | Centre Hospitalier Universitaire de Nice | Facioscapulohumeral Muscular Dystrophy Type 2 | 04/26 | 04/26 | | |
TELE-MIT, NCT05346627: Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance. |
|
|
| Recruiting | N/A | 15 | Europe | Personalized and mixed training program | Centre Hospitalier Universitaire de Nice | Mitochondrial Myopathies | 06/26 | 06/26 | | |
| MOCERI, PAMELA |
MYOCOVID, NCT04375748: Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases |
|
|
| Completed | N/A | 756 | Europe, RoW | Performing routine care (clinical and paraclinical tests), Examinations for the research: | University Hospital, Toulouse | Acute Myocarditis | 12/21 | 12/21 | | |
| Recruiting | N/A | 100 | Europe | | Centre Hospitalier Universitaire de Nice | Heart Failure | 12/24 | 12/25 | | |
| GIORDANA, Caroline |
| Active, not recruiting | 3 | 134 | Europe | Apomorphine, Apokinon, Best Medical Treatment | Rennes University Hospital | Parkinson's Disease | 12/23 | 01/25 | | |
ACTIVATE, NCT05819359: Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD |
|
|
| Active, not recruiting | 2 | 237 | Europe, Canada, US | BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo | Bial R&D Investments, S.A. | Parkinson's Disease | 03/26 | 07/26 | | |
AWAKENING, NCT06401395: Clinical Evaluation of A neW Management Strategy for Patients With pArKinson's disEase usiNg an Innovative telemonitorING |
|
|
| Not yet recruiting | N/A | 300 | Europe | DIGIPARK MONITOR | DIAMPARK, Weprom, Digital Medical Hub | Parkinson Disease | 01/27 | 08/27 | | |
PERSO-PERF, NCT06080399: Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease |
|
|
| Recruiting | N/A | 70 | Europe | Continuous subcutaneous apomorphine infusion (CSAI) | University Hospital, Toulouse, ELIVIE France, EVER Pharma France SAS, NHC SAS, France, Orkyn', ETPARK Association, Toulouse, France | Parkinson Disease | 04/26 | 04/26 | | |
| Recruiting | N/A | 30 | RoW | Video-oculography / Neuropsychological evaluations | Association de Recherche Bibliographique pour les Neurosciences, Centre Hospitalier Princesse Grace, Centre Hospitalier Universitaire de Nice | Parkinson Disease, Idiopathic | 01/32 | 01/32 | | |
| Recruiting | N/A | 1000 | Europe, US, RoW | Deep Brain Stimulation (DBS) | Abbott Medical Devices | Movement Disorders, Parkinson Disease, Essential Tremor, Tremor, Dystonia, Primary Dystonia, Secondary Dystonia | 09/29 | 09/30 | | |
| VANBIERVLIET, Geoffroy |
| Recruiting | N/A | 1500 | Europe | Collection of biological samples | University Hospital, Toulouse | Pancreatic Adenocarcinoma | 11/26 | 11/26 | | |
FAMCAP, NCT02738359: Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening |
|
|
| Recruiting | N/A | 3250 | Europe | optical colonoscopy, colon capsule endoscopy, fecal immunological test (FIT) | Hôpital Edouard Herriot, National Cancer Institute, France, Medtronic | Colon Cancer, Rectum Cancer | 11/21 | 11/24 | | |
| Completed | N/A | 176 | Europe | Hot AXIOS® prosthesis | Centre Hospitalier Universitaire de Nice | Pancreatitis,Acute Necrotizing | 11/23 | 11/23 | | |
| Completed | N/A | 111 | Europe | | University Hospital, Bordeaux | Achalasia | 02/24 | 02/24 | | |
ENDOBARRETT, NCT04867590: A Study Comparing the Effectiveness of EndoRotor Versus Radiofrequency in Treating Barrett's Esophagus |
|
|
| Recruiting | N/A | 140 | Europe | Endorotor, Radiofrequency | University Hospital, Angers | Barrett Esophagus, Dysplasia | 03/26 | 05/27 | | |
CONVERSE, NCT05229783: High Resolution Virtual Chromoendoscopy Versus Seattle Protocol for the Surveillance of Barrett's Esophagus |
|
|
| Recruiting | N/A | 110 | Europe | Electronic chromoendoscopy, White light endoscopy with Seattle protocol | Nantes University Hospital | Barrett Esophagus | 09/25 | 09/25 | | |
| DEMONCHY, Elisa |
NCT02701608: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus |
|
|
| Recruiting | 3 | 324 | Europe | Levofloxacin, Fluoroquinolones, Rifampicin, Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine | University Hospital, Tours | Infective Endocarditis | 05/24 | 09/24 | | |
NCT02701595: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus |
|
|
| Recruiting | 3 | 324 | Europe | Amoxicillin, Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin | University Hospital, Tours | Infective Endocarditis | 05/24 | 09/24 | | |
